chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Intense tingling sensation in my head, spine and face immediately.  My face still has a constant tingling sensation. A week after my vaccine, I had an intense burning sensation in my chest and spine that kept me up all night. I went to urgent care the next day. It felt like someone had put icy/hot on my body. That sensation comes and goes, but the face tingling has remained constant since my shot.
No other symptoms reported at this time; A pediatric patient received VAQTA twice; This spontaneous report was received from a physician referring to a 2 year-old pediatric patient whose gender was not specified. No information regarding the patient's pertinent medical history, concurrent conditions, concomitant medication, previous drug reactions, or allergies was provided.  On 20-SEP-2021, the patient received an hepatitis a vaccine, inactivated (VAQTA) twice, at a dose of  0.5 milliliter (ml) (dose number, vaccination scheme, route of administration, anatomical location of vaccination, lot number and expiration date were unknown by the reporter) as prophylaxis (extra dose administered). No symptoms were reported (no adverse event).
2 weeks after vaccine developed slurred speech, difficulty with speech, ptosis and processive weakness.  Diagnosed with myasthenia gravis.
Patient reports feeling ill x 4 weeks prior to coming into hospital. He tested negative for COVID on 12/21/21. Came into ED with fatigue and dyspnea with minimal activity. Does desaturate into 80% for oxygenation with abmulation.  Patient was primarily admitted due to his acute kiney failure on top of CKD stage 4.
Muscle ache for two months resulting in frozen shoulder.  Physical therapy started 11/24/2010.
Information has been received from a health care worker (also the patient) with no pertinent medical history or drug reaction/allergy who "about 10 years ago" (in approximately 2001) was vaccinated with HepB (lot# and manufacturer unknown). There was no concomitant medication. On an unknown date, the patient did "blood test" and reported that "she did not have a positive titer after receiving the 3 dose series of HepB (manufacturer was unknown)". No treatment was given for the adverse event. The patient did not seek medical attention. At the time of report, the outcome of the adverse event was unknown. Additional information has been requested.
Received vaccination on 03/12/2021 at 4:04PM. Symptom onset 03/13/2021 around 10:00AM: soreness at injection site (left deltoid muscle), soreness in leg muscles, fatigue, nausea, chills, dizziness, runny nose, cough, and worry.  Axillary temperature: 98.6F.
This spontaneous report was received from a back office lead and refers to a 28 year old patient of unknown gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 26-MAR-2016, the patient was vaccinated with an improperly stored dose of VAQTA lot # L018498 (expiration date was not provided), 1 ml, intramuscularly, in left deltoid (dose number was not provided). There was no adverse effect reported. This is one of several reports received from the same reporter. Additional information has been requested.
This spontaneous report was received from a pharmacist concerning an approximately 60 year old female patient. The patient has no pertinent medical history and drug reactions. The pharmacist was reported that on 04-NOV-2013, the patient was vaccinated with ZOSTAVAX (lot number: J004269 and expiry date: 12-JUL-2014) 0.65 ml subcutaneously). No concomitant therapy was reported. No adverse effect was reported. The pharmacist stated that on 06-NOV-2013, the patient called and informed him that she developed a 2"3 flat red area at injection site that is a little itchy after receiving the ZOSTAVAX. The pharmacist instructed to patient over the phone to apply a cold cloth to the injection site as treatment. The patient was called to pharmacist as to sought medical attention. At the time of report the patient was not recovered from the events. The causality for the events was unknown with the ZOSTAVAX. Additional information has been requested.
Breakthrough COVID infection in fully vaccinated patient. Positive date 08/11/2021.
Pt does not have Card with lot # Pt reports dry mouth, paranesthesia to tongue and uncontrollable movements  of mouth. This occurred 24+hours after vaccination. On physical examination she had dry mucus membranes. Symptoms resolved after Ativan, IVF and Ice chips.   DDX includes dystonic reaction vs. acute panic attack/anxiety vs. ingestion (pt denies).
No additional AE reported.; the PEDVAXHIB has been administered to the patient after the excursion occurred; This spontaneous report has been received from a nurse practitioner via customer, referring to a patient of unknown age and gender. The patient's historical condition, current condition and concomitant drug  were not reported.  On 12-MAY-2022, the patient was vaccinated with haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) (lot # U024090 with expiration date: 28-OCT-2023, 0.5 milliliter, strength and route were not reported) for prophylaxis after the excursion occurred (product storage error).   A temperature excursion evaluation was not performed at the time of the call. The complete cumulative time and temperature details were unknown until the customer returned the multiple excursion form that was submitted to the reporter. The previous temperature was unknown by reporter. No additional information provided. No additional adverse event reported.
Pt reports sore throat and hives to bilateral upper extremities one day after 1st dose of Moderna.
Patient stated has fever, redness and increase in fasting blood sugar level. She is diabetic. She was seen by her primary care physician and received antibiotic on 6/7/2016.
Vaccine received 10/26/05. Had brief URI with low grade fever 1 week prior with normal exam. 10/27/05 Began with recurrent lip smacking and drowsiness. EEG consistent with focal seizures. Information from 60 day report states: Ongoing seizure disorder controlled with medication. Felt due to cerebral malformation and not due to influenza vaccine. As per follow up report, reproter wrote to correct pts last name and provided the following information. MRI revealed developmental abnormality on left temporal cortex in hospital, thus neurological conclusion is that is a congenital condition not vaccine related. Medical records state cough. msv
Seriousness criteria other Medically significant (OMIC). A 24 year old male pt with a history of asthma and allergy of Vicodin received doses of YF Vax, influenza vaccine (Manufacturer unk), Hepatitis A vaccine (manufacturer unk), Hepatitis B vaccine (manufacturer unk), and Typhoid vaccine (manuf unk), in mid October 2006. The lot numbers were reported as unk. The routes and dates of administration were not reported. As per the reporter, all of the vaccines except for the YF Vax were administered at another facility. Approx two days after receiving the vaccines, the pt complained of a general headache, right pupil enlargement and blurred eyesight in his right eye. The pt used a scopolamine patch approx six to seven hours after the pupil changes were noted. He was evaluated at an emergency room, where he was diagnosed with possible meningitis ore questionable mild encephalitis. An MRI and CBC chemistry were all neg. The condition resolved and the pt recovered from the events.
Flu-like symptoms, chills felt hot and cold swollen, under lymph nodes under left arm and left side of neck X 3 day left side of neck hurt. On 1/28/02, her upper back by top of spin hurts. Vaccine reaction reported on 2-14-02
Received Moderna covid vaccination 1/14/2021. 1/16/2021 received report of cough and difficulty breathing.  Proceeded to hospital and was diagnosed Covid+ on testing. Continued to decline,  died 1/31/2021.
About 5 minutes after administration patient began feeling dizziness like she was going to pass out, sweats, blurred vision, ears ringing, bilateral hands tingling, lethargic, slurred speech, color pale. Vitals were monitor, pulse low, BP not reading, 911 was called. cool compresses were applied to patient neck. Within 25 minutes patients symptoms began improving more responsive, speech normal, color normal, BP and pulse WNL.  Paramedics evaluated patient for stability and was clear to return home
Chest tightness, Difficulty in breathing, Tachycardia, Throat tingling and burning.
Approximately 3 minutes after MMR injection, pt went limp and back in the chair and his body was shaking for about 5 seconds. After sitting him up, he was alert and oriented complaining of headache and nausea. He only had coffee for breakfast. We gave him cookies and water. About 5 minutes later, pt had no complaints. Vital signs were stable. Pt was then seen by MD.
Headache, tenderness, mild swelling and warmth. MD recommended ice, NSAIDs.
SORENESS AT SITE DAY AFTER, BRUISIN G THE SIZE OF HALF A BASEBALL AFTERWARDS, STILL HAS SHOULDER PAIN ALMOST TWO MONTHS AFTERWARDS
Slight numbness on tongue and right side of mouth.  Resolved with monitoring for 30 minutes
NO OTHER AE; The caller said inadverntently administered a dose expired of GARDASIL 9; This spontaneous report has been received from a nurse, concerning patient of unknown age and gender. No information was provided regarding the patient's pertinent medical history, concomitant medications, current conditions, previous drug reactions, or allergies.  On 11-FEB-2022, the patient was inadvertently vaccinated with one expired dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) as prophylaxis (lot number 1581027 has been verified to be a valid lot number, expiration date reported and established as 03-JUN-2021) (exact dose, route and anatomical location of administration were not reported) (expired product administered). No other adverse events (AE) reported (no adverse event), no temperature excursion occurred prior to administration.
This is a spontaneous report from a contactable consumer (patient). This 74-year-old female patient received a single dose of PREVNAR 13, via an unspecified route of administration at the age of 73-years on 06Mar2015. Medical history included blood pressure, thyroid disorder and she took levothyroxine for that, diverticulitis from 2013 and she did not take any medication for it. She had that attack in 2013. Concomitant medications included lisinopril, levothyroxine and TYLENOL. The patient might have polymyalgia rheumatica on an unspecified date with outcome of unknown, she had all kind of pain/ache all over on 11Mar2015 with outcome of unknown, shot pain never left in her shoulder but that was minor/pain went on from her elbow to then her shoulder on 11Mar2015 with outcome of not recovered, pain in both arm from her wrist and elbow on 11Mar2015 with outcome of unknown, little bit of stuck blood in her eye on an unspecified date with outcome of unknown, lost her weight around 18 pound on an unspecified date with outcome of unknown, she had gained weight on an unspecified date with outcome of unknown, she got perm in her hair it did not take for first time/hair were like straw on an unspecified date with outcome of unknown, finger nails are short, stubby, break off and now they were in layers on an unspecified date with outcome of unknown, skin was dry on an unspecified date with outcome of unknown, pain in both arm from her wrist and elbow on 11Mar2015 with outcome of unknown. Therapeutic measures were taken as a result of had all kind of pain/ache all over, shot pain never left in her shoulder but that was minor/pain went on from her elbow to then her shoulder, pain in both arm from her wrist and elbow, pain in both arm from her wrist and elbow. The patient mentioned that she went to doctor and they run some blood work in Aug2015. She mentioned that her doctor gave her TYLENOL for discomfort. The patient mentioned that she went to her rheumatologist and he put her on prednisone. She was trying to wean herself off of that because of dangerous effects of that and TYLENOL for the pain she was having from PREVNAR 13. The patient also mentioned that her rheumatologist told her that might be it was polymyalgia rheumatica.
pt recvd vax & became feverish; chills; sweats; gen achiness; dizzy; felt very weak; some food allergies; symp lasted 3 days;
pt recvd vax had large red area on upper arm size of a hand; muscular soreness & redness under arm; consulted MD did not see MD took APAP;
SM received 2nd vaccine and was monitored for 15 minutes. Returned to her workplace at WDL, began to feel flushed, face became red, chest red, co workers escorted her to IOH. Assessed - SM states throat feels like a lump, face and chest very warm and red, back warm.  Benadryl administered. In contact with vaccine team. RRT called when symptoms did not rescind after 20 minutes. RRT team here and Sm assess. DR here and assessed. 2nd dose of Benadryl given. SM monitored until stable. Redness went down, light rash on chest, injection site without swelling or redness. Slight headache -she states from mask, denies nausea, denies SOB Discharged to home per W/C to truck, husband drove SM home.
Patient states that she was drinking water and started coughing at about 5pm. At this point, she states that she felt "her lymph nodes in her neck area drop and feels heavy". She called and spoke with me at the pharmacy about 5:30pm. I explained to her that swollen lymph nodes can be a possible side effect (though rare) and that she should monitor her condition. She may apply a warm compress to the affected area and to take an OTC anti-inflammatory for relief.
Information has been received from a physician concerning a 23 year old white female who on 13-AUG-2008 was vaccinated with the first dose of GARDASIL (lot no. 0250X). On 13-AUG-2008, after the vaccination, the patient felt lightheaded and left the treated room and fainted. The patient fell to the floor. The patient was not injured. Patient was un-injured. Subsequently the patient recovered fine and wanted to continue the series of GARDASIL. No further information is available.
3AUG92 mom describes a brief grand mal sz w/o any fever; previously mom had reported the site of DTP was hard & red & swollen about 6 cm induration;
A few days after vaccine I developed slight SOB, coughing, heavy/tight chest mostly at night time but also during the day at times. At the time I did not have a PCP to turn to so I suffered with this for months with persisting and worsening SOB and wheezing. Once I established with PCP on 3/10/20 I addressed the issues and she sent me to a pulmonologist. he did not believe me when I told him these symptoms developed after the vaccine and refused to acknowledged it in my health care chart.
By history from pt, this is the 3rd  incident of a significant local reaction associated with Anthrax vaccine. Has numerous papules on erythematous base. Pruritic around area of injection and has increased in severity each successive shot. This reaction is with 50-60 erythematous papular lesions in about .5-1 mm size developed in left triceps, left lumbar and on thighs. Treatment prescribed 2/20/2000, Benadryl. Condition improved but leaves scars as they heal.
11-21-06 onset with fever (102-103), red spot on Left thigh, seen in ER. 11-25-06 office visit Left thigh with nontender, 1cm nodular erythematous patch, ?? early superficial veseculation. Bilateral inguinal adenopathy 1cm 3-4 each side. Treatment: warm soaks, treat fever, close observation.
Headache almost every day starting 5/15/04 through sick visit on 5/20/04 until 3-4 days later.
Approximately two weeks after the first dose, lymph nodes in the left armpit began to swell to the size of large grapes and become tender. Three weeks after the initial dose, multiple lymph nodes in the right armpit began to swell and become tender. The lymph nodes are still swollen and tender at the time of this report.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 12-AUG-2015 the patient inadvertently received an expired first dose of GARDASIL (dose, strength and route were not reported) lot # H020002 with expiry date: 08-AUG-2015. No concomitant medications were reported. No adverse experiences have been reported so far. There were no product quality complaints (PQC) involved. This is one of several reports received from the same reporter. Additional information has been requested.
MD reported that pt is pos for HEPBSAG & antiHEPBSAG antibodies p/receiving 3 doses of Engerix-B;
Fever, Nausea, Diarrhea, Chills, Right Arm Pain at injection site.
Large red welt on arm at site where vaccination (pneumo shot) was administered. Slight fever. Physician's diagnosis cellulitis. Site is warm and sore to touch.
Convulsions, Shaking, High Fever. Follow-up: Immune system problems, gastrointestinal pain, Autism.
macular rash on shoulders down to elbows from hips to knees & on stomach, given 1 dose of DPH per MD;rash resolving on second day;
continue allergic reaction with Pfizer COVID vaccine; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from a sales representative.  A female patient received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HYPERSENSITIVITY (non-serious), outcome "unknown", described as "continue allergic reaction with Pfizer COVID vaccine".  Additional Information: It was reported that the adverse event took place after the use of Pfizer product.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
rt arm stiffness, pain, blotchy red rash covering shoulder to hand, breathing difficulties;
RN administering patient his second Moderna Vaccine--(1st had been administered/recorded 9/28/21)--incorrectly administered a booster size dose (0.25ml) instead of full dose of 0.5ml.  Patient left clinic--it was then noted by Phamacist that count was off. Confirmed the dose that had been drawn up for him by Phamacist, had not been administered. Instead the count was off by 1 for the 1/2 dose Moderna vaccines.  Once identified as error, patient was called back into clinic--and administered another 1/2 dose on 1/8 (2 days later)--bringing him whole in his vaccination status.
The patient did not have any adverse effects; A patient received two doses of GARDASIL 9 from two different HCPs, at the same time.; The patient received second and third dose of Gardasil 9 at the samte time; This spontaneous report was received from a physician and refers to a 13-year-old female patient. The patient's concurrent conditions, drug reaction or allergies and pertinent medical history were not reported.   On unknown date, the patient was vaccinated with a first dose of with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) for prophylaxis (quantity dose, lot #, expiration date and route we not reported)  On 23-JAN-2023 from two different healthcare professionals, the patient received at the same time  two doses of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9), 0.5 milliliter, for prophylaxis (lot #, expiration date and route we not reported). The patient was scheduled to receive the two-dose series (overdose and inappropriate schedule of product administration). Concomitant therapies included influenza vaccine.  The physician did not report any adverse effects (no adverse event) and nor product quality complain.
tested positive for COVID-19 on 11Feb2021; This is a spontaneous report from a contactable consumer (patient). A 75-year-old female received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; solution for injection) via an unspecified route of administration on 08Feb2021 as a single dose for COVID-19 immunization. Medical history included lymphedema and cellulitis, both from an unspecified date and unspecified if ongoing. Concomitant medications were not reported. The patient tested positive for COVID-19 on 11Feb2021. The patient stated that this "was a unique situation as she was experiencing a bout of cellulitis because of her lymphedema and she experienced this almost annually." During her COVID-19 diagnosis she was treated with bamlanivimab. The patient was scheduled to receive her second dose of the Pfizer COVID-19 vaccine today and she wanted to know if she was okay to proceed with receiving the second dose considering her recent COVID-19 diagnosis. The patient wanted to know if the bamlanivimab that she received would cause the second dose of the Pfizer COVID-19 vaccine to be less effective. The caller stated that she spoke with the manufacturer of this drug, and they let the caller know that bamlanivimab could potentially decrease the potential for creating antibodies after receiving a COVID-19 vaccine. She also wanted to know if it was possible that the vaccine caused a false positive test result. The clinical outcome of the event tested positive for COVID-19 on 11Feb2021 was unknown.  Information about lot/batch number has been requested.
Severe bruising and pain at sight of injection.  Bruise is about 2" diameter. Patient states got antibiotics and cream to treat it. Patient thinks vaccine was expired or immunizer gave shot wrong...
pt c/o feeling lightheaded, dizzy, faint; she was escorted to a cot to lie down for several minutes, she used an ice pack on her head and neck; she never lost consciousness; she eventually stated that she felt better and left the premises on her own
The next day I had a sore arm which was expected. I also started with chills, extreme fatigue, headaches, and muscle soreness since receiving the vaccine and the symptoms still ongoing  with today being 1/12/21.
Pt described chest heaviness, nausea, headache after administration of vaccine presented next day with persistent complaint.  3/10/09 Received PCP medical records of 2/10/09. FINAL DX: ? reation to Gardasil Records reveal patient w/chest heaviness, lightheaded, within few minutes of shot.  RTC 2/10 w/nausea, HA, lightheadedness, left shoulder w/full ROM, no redness or tenderness.
HEAVINESS IN ONE LEG; NUMBNESS IN HER TOES ON ONE SIDE; This spontaneous report received from a pharmacist concerned a 23 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 205A21A, expiry: 18-SEP-2021) dose was not reported, administered on 07-AUG-2021 for prophylactic vaccination. No concomitant medications were reported. On AUG-2021, the patient experienced heaviness in one leg. On AUG-2021, the patient experienced numbness in her toes on one side. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the heaviness in one leg and numbness in her toes on one side was not reported. This report was non-serious.